CD90 is positively correlated with clinicopathologic characteristics, including pathological grade, satellite lesions, PVTT, and recurrence, suggesting a role as a predictor of poor prognosis in CAFs, and is consistently determined as a reliable biomarker for prognosis of HCC patients subjected to hepatic resection [104]. Here, THY1 is linked to hepatocellular carcinoma.